199 related articles for article (PubMed ID: 20722672)
1. Who attends a UK diabetes screening programme? Findings from the ADDITION-Cambridge study.
Sargeant LA; Simmons RK; Barling RS; Butler R; Williams KM; Prevost AT; Kinmonth AL; Wareham NJ; Griffin SJ
Diabet Med; 2010 Sep; 27(9):995-1003. PubMed ID: 20722672
[TBL] [Abstract][Full Text] [Related]
2. Record-based, stepwise screening for type 2 diabetes integrated into an annual cardiovascular care review system: Findings from a UK general practice.
Fisher BG; Ang YL; Goodhart C; Simmons RK
Prim Care Diabetes; 2011 Dec; 5(4):265-9. PubMed ID: 21968319
[TBL] [Abstract][Full Text] [Related]
3. Screening for type 2 diabetes: literature review and economic modelling.
Waugh N; Scotland G; McNamee P; Gillett M; Brennan A; Goyder E; Williams R; John A
Health Technol Assess; 2007 May; 11(17):iii-iv, ix-xi, 1-125. PubMed ID: 17462167
[TBL] [Abstract][Full Text] [Related]
4. Screening for type 2 diabetes. Lessons from the ADDITION-Europe study.
van den Donk M; Sandbaek A; Borch-Johnsen K; Lauritzen T; Simmons RK; Wareham NJ; Griffin SJ; Davies MJ; Khunti K; Rutten GE
Diabet Med; 2011 Nov; 28(11):1416-24. PubMed ID: 21679235
[TBL] [Abstract][Full Text] [Related]
5. Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms.
Christensen JO; Sandbaek A; Lauritzen T; Borch-Johnsen K
Diabetologia; 2004 Sep; 47(9):1566-73. PubMed ID: 15365615
[TBL] [Abstract][Full Text] [Related]
6. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial.
Simmons RK; Echouffo-Tcheugui JB; Sharp SJ; Sargeant LA; Williams KM; Prevost AT; Kinmonth AL; Wareham NJ; Griffin SJ
Lancet; 2012 Nov; 380(9855):1741-8. PubMed ID: 23040422
[TBL] [Abstract][Full Text] [Related]
7. The cost-effectiveness of testing strategies for type 2 diabetes: a modelling study.
Gillett M; Brennan A; Watson P; Khunti K; Davies M; Mostafa S; Gray LJ
Health Technol Assess; 2015 May; 19(33):1-80. PubMed ID: 25947106
[TBL] [Abstract][Full Text] [Related]
8. Screening for type 2 diabetes: a short report for the National Screening Committee.
Waugh NR; Shyangdan D; Taylor-Phillips S; Suri G; Hall B
Health Technol Assess; 2013 Aug; 17(35):1-90. PubMed ID: 23972041
[TBL] [Abstract][Full Text] [Related]
9. A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study.
Simmons RK; Borch-Johnsen K; Lauritzen T; Rutten GE; Sandbæk A; van den Donk M; Black JA; Tao L; Wilson EC; Davies MJ; Khunti K; Sharp SJ; Wareham NJ; Griffin SJ
Health Technol Assess; 2016 Aug; 20(64):1-86. PubMed ID: 27583404
[TBL] [Abstract][Full Text] [Related]
10. [Detection of a previously unrecognized type 2 diabetes using a risk questionnaire. Efficiency for general population screening].
Scherbaum WA; Dicken HD; Verheyen F; Baehring T
Dtsch Med Wochenschr; 2006 Oct; 131(40):2208-12. PubMed ID: 17021988
[TBL] [Abstract][Full Text] [Related]
11. The cost of diagnosing Type 2 diabetes mellitus by clinical opportunistic screening in general practice.
Pereira Gray DJ; Evans PH; Wright C; Langley P
Diabet Med; 2012 Jul; 29(7):863-8. PubMed ID: 22313143
[TBL] [Abstract][Full Text] [Related]
12. Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models.
Davis A; Smith P; Ferguson M; Stephens D; Gianopoulos I
Health Technol Assess; 2007 Oct; 11(42):1-294. PubMed ID: 17927921
[TBL] [Abstract][Full Text] [Related]
13. Irish diabetes detection programme in general practice.
Smith SM; Holohan J; McAuliffe A; Firth RG
Diabet Med; 2003 Sep; 20(9):717-22. PubMed ID: 12925050
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different stepwise screening strategies for type 2 diabetes: Finding from Danish general practice, Addition-DK.
Dalsgaard EM; Christensen JO; Skriver MV; Borch-Johnsen K; Lauritzen T; Sandbaek A
Prim Care Diabetes; 2010 Dec; 4(4):223-9. PubMed ID: 20675208
[TBL] [Abstract][Full Text] [Related]
15. Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening.
Webb DR; Khunti K; Srinivasan B; Gray LJ; Taub N; Campbell S; Barnett J; Henson J; Hiles S; Farooqi A; Griffin SJ; Wareham NJ; Davies MJ
Trials; 2010 Feb; 11():16. PubMed ID: 20170482
[TBL] [Abstract][Full Text] [Related]
16. Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: a randomised controlled trial in British general practice.
Park P; Simmons RK; Prevost AT; Griffin SJ
BMC Public Health; 2008 Oct; 8():350. PubMed ID: 18840266
[TBL] [Abstract][Full Text] [Related]
17. Let's prevent diabetes: study protocol for a cluster randomised controlled trial of an educational intervention in a multi-ethnic UK population with screen detected impaired glucose regulation.
Gray LJ; Khunti K; Williams S; Goldby S; Troughton J; Yates T; Gray A; Davies MJ;
Cardiovasc Diabetol; 2012 May; 11():56. PubMed ID: 22607160
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of two confirmatory tests for diabetes mellitus in adult Ugandans with recently diagnosed tuberculosis.
Kibirige D; Zawedde-Muyanja S; Andia-Biraro I; Olum R; Adakun S; Sekaggya-Wiltshire C; Kimuli I
Ther Adv Infect Dis; 2023; 10():20499361231216799. PubMed ID: 38145193
[TBL] [Abstract][Full Text] [Related]
19. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
20. Estimating the potential population impact of stepwise screening strategies for identifying and treating individuals at high risk of Type 2 diabetes: a modelling study.
Chamnan P; Simmons RK; Khaw KT; Wareham NJ; Griffin SJ
Diabet Med; 2012 Jul; 29(7):893-904. PubMed ID: 22340130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
